Conclusions and Reflections

被引:3
作者
Denis, Louis J. [1 ]
Gospodarowicz, Mary K. [2 ]
机构
[1] Ctr Oncol, B-2000 Antwerp, Belgium
[2] Princess Margaret Hosp, Radiat Med Program, Toronto, ON M4X 1K9, Canada
关键词
prostate cancer; prediction; treatment; results;
D O I
10.1002/cncr.24343
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Validated prognostic factors are an integral part of any cancer diagnosis. The available proliferation of new markers and randomized clinical trial results leads to a complex decision making looking for optimal treatment and outcome results. Advanced mathematic models have been developed to weigh each specific prognostic factor into a single outcome number in nomograms modeled for specific predictive accuracy in key phases of the treated history of the disease. Despite this progress, it is important to realize that the results are an outcome stratification for groups rather than for the individual patient. It is clear that in the tumor prognosis, host and environmental factors need to be evaluated before any clinical decision is made. Cancer 2009;115(13 suppl):3160-2. (C) 2009 American Cancer Society.
引用
收藏
页码:3160 / 3162
页数:3
相关论文
共 8 条
[1]  
BRODERS AC, 1940, TREATMENT CANCER ALL, V1, P19
[2]  
Denis LJ, 2006, PROGNOSTIC FACTORS C, P247
[3]  
Denoix PF., 1945, B I NAT HYG PARIS, V2, P82
[4]  
Denoix PF, 1950, B I NAT HYG PARIS, V5, P81
[5]  
Denoix PF., 1944, Bull Inst Nat Hyg (Paris), P69
[6]  
Denoix PF, 1952, B I NAT HYG PARIS, V7, P743
[7]  
Gospodarowicz MK., 2006, Prognostic factors in cancer
[8]   THE USE OF PROSTATE-SPECIFIC ANTIGEN, CLINICAL STAGE AND GLEASON SCORE TO PREDICT PATHOLOGICAL STAGE IN MEN WITH LOCALIZED PROSTATE-CANCER [J].
PARTIN, AW ;
YOO, J ;
CARTER, HB ;
PEARSON, JD ;
CHAN, DW ;
EPSTEIN, JI ;
WALSH, PC .
JOURNAL OF UROLOGY, 1993, 150 (01) :110-114